Eli Lilly and Co
F:LLY
Eli Lilly and Co
F:LLY
Price:
826.6
EUR
4.24%
Market Closed
Market Cap:
€785.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Eli Lilly and Co
F:LLY
|
US |
|
Check Point Software Technologies Ltd
NASDAQ:CHKP
|
IL |
|
PepsiCo Inc
NASDAQ:PEP
|
US |
|
Berry Corporation (Bry)
NASDAQ:BRY
|
US |
|
J
|
John Menzies PLC
F:B3N
|
UK |
|
K
|
Kwung's Holdings Ltd
HKEX:1925
|
CN |
|
S
|
Sea Ltd
SWB:931
|
SG |
|
B
|
Benguet Corp
XPHS:BC
|
PH |
|
I
|
Izdemir Enerji Elektrik Uretim AS
IST:IZENR.E
|
TR |
|
Balkrishna Paper Mills Ltd
NSE:BALKRISHNA
|
IN |
|
B
|
BW Energy Ltd
OSE:BWE
|
BM |
|
NTG Nordic Transport Group AS
CSE:NTG
|
DK |
|
Nuvista Energy Ltd
TSX:NVA
|
CA |
|
Metal Powder Works Ltd
ASX:MPW
|
AU |
|
L
|
Lumi Rental Co
SAU:4262
|
SA |
|
T
|
Techna-X Bhd
KLSE:TECHNAX
|
MY |
|
F
|
Fabasoft AG
XBER:FAA
|
AT |
|
S
|
Syensqo SA
XBRU:SYENS
|
BE |
|
Radian Group Inc
NYSE:RDN
|
US |
|
Shattuck Labs Inc
NASDAQ:STTK
|
US |
Multiples-Based Value
The Multiples-Based Value of one
LLY
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 826.6 EUR,
Eli Lilly and Co
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LLY Multiples-Based Value
LOCKED
Multiples Across Competitors
LLY Competitors Multiples
Eli Lilly and Co Competitors
Eli Lilly and Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
F:LLY
|
883.9B EUR | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 | |
| FR |
|
Sanofi SA
PAR:SAN
|
99.8B EUR | 2.1 | 12.8 | 10.6 | 10.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
